
Heather Woolery-Lloyd, MD, an expert on the management of acne, recaps a recent Case-Based Roundtable discussion, highlighting two patient cases and providing insights on available therapies and treatment practices.

Heather Woolery-Lloyd, MD, an expert on the management of acne, recaps a recent Case-Based Roundtable discussion, highlighting two patient cases and providing insights on available therapies and treatment practices.

Rocco Serrao, MD, FAAD, addresses the challenges of managing vitiligo across various age groups and skin types, emphasizing the psychological impact of the disease. He investigates obstacles to the adoption of new topical treatments, advocates for the integration of prior authorization processes and raises awareness about the implications of vitiligo affecting a larger body surface area.

Matthew J. Zirwas, MD, summarizes insights from a case-based round table conversation, that reviews the management of patients with atopic dermatitis. He sheds light on difficulties in ensuring an accurate diagnosis, treatment complexities, and addresses the utility of topical treatments for this condition.

An expert in the management of skin conditions reviews the management of atopic dermatitis with a special emphasis on hand and foot involvement. She shares her expertise by reviewing real-world scenarios and practical strategies for optimizing patient care in these challenging areas.

An expert in dermatology provides insights from a case-based round table conversation, discussing the management of atopic dermatitis patients. He emphasizes the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based roundtable conversation, discussing the management of atopic dermatitis patients. They emphasize the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

Experts in dermatology provide insights from case-based roundtable conversations, discussing the management of patients with vitiligo. They emphasize the complexities of inherent to the management of this condition, the available treatment options and the administrative challenges associated with prior authorizations.

Experts in dermatology provide insights from case-based roundtable conversations, discussing the management of patients with vitiligo. They emphasize the complexities of inherent to the management of this condition, the available treatment options and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based dinner conversation, discussing the management of atopic dermatitis patients. They emphasize the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

Experts in dermatology provide insights from case-based roundtable conversations, discussing the management of patients with vitiligo. They emphasize the complexities of inherent to the management of this condition, the available treatment options and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based round table conversation, discussing the management of atopic dermatitis patients. He emphasizes the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based discussion, discussing the management of atopic dermatitis patients. He emphasizes the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based round table conversation, discussing the management of atopic dermatitis patients. She emphasizes the complexities of the cases, the considerations regarding topical versus systemic treatments, and the administrative challenges associated with prior authorizations.

An expert in dermatology provides insights from a case-based roundtable conversation, discussing the management vitiligo across diverse age groups and skin types. The discussion centers on understanding the challenges posed by vitiligo, addressing its impact on patients' well-being. The conversation emphasizes effective education and communication strategies and shines a spotlight on the intricacies of treating non-facial areas.

Experts in dermatology provide insights from case-based roundtable conversations, discussing the management of patients with vitiligo. They emphasize the complexities of inherent to the management of this condition, the available treatment options and the administrative challenges associated with prior authorizations.

Omar Noor, MD, FAAD, provides insights from a case-based discussion, wherein he navigates the complexities surrounding patient care, emphasizing the critical importance of patient education, trust-building, and equitable access to care. He also explores the nuanced implications of boxed warnings linked to JAK inhibitors, drawing attention to variations between systemic and oral forms of topical ruxolitinib, and their potential influence on dialogues with patients and fellow healthcare providers.

An expert in dermatology provides insights from a case-based conversation, discussing the management of atopic dermatitis patients. He emphasizes the complexities of the cases, the considerations regarding topical vs systemic treatments, and the administrative challenges associated with prior authorizations.

Experts in dermatology discuss the practical management of patients with generalized pustular psoriasis (GPP) through a panel discussion and case-based study review.

Mark G. Lebwohl, MD, presents two patient cases of Generalized Pustular Psoriasis and discusses his approach to treatment and the impact of a recent therapeutic approval.